Overview

Follow-up Study for Participants of Jointstem Phase 3 Clinical Trial

Status:
Enrolling by invitation
Trial end date:
2027-12-30
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this follow-up study is to investigate the efficacy and safety of autologous Adipose Tissue derived Mesenchymal stem cells (JOINTSTEM®) in patient with severe Knee Osteoarthritis.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
R-Bio
Criteria
Inclusion Criteria:

- Participants of Jointstem Phase 3 Clinical Trial

- Participates who signed informed consent document of this study

Exclusion Criteria:

- No applicable